Working… Menu

Weight Loss as Treatment in Heart Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02105805
Recruitment Status : Completed
First Posted : April 7, 2014
Last Update Posted : April 7, 2014
University Hospital, Gentofte, Copenhagen
Information provided by (Responsible Party):
Arne Astrup, University of Copenhagen

Brief Summary:

30 obese moderate-to-severe heart failure patients will be randomized to intervention or control in groups of 5-10 subjects.

All will receive dietetic advice according to randomization and according to the European Heart Association.

Intervention subjects will initiate with 8 weeks low energy diet, 800-1000 kcal/d by formula diet and subsequent four weeks reintroduction to regular foods supplying 1200 kcal/d substituting two daily meals with formula meal replacement.

Control subjects are advised to follow the Nordic Nutrition Recommendations.

Patients will be monitored by blood sampling and assessed by change in physical performance.

Condition or disease Intervention/treatment Phase
Heart Failure Behavioral: Dietetic group sessions Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Intentional Weight Loss as Treatment in Obese Patients With Ischaemic Heart Disease
Study Start Date : October 2010
Actual Primary Completion Date : August 2011
Actual Study Completion Date : August 2011

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: low energy diet
low energy diet treatment
Behavioral: Dietetic group sessions
Group sessions to improve dietary adherence

Active Comparator: Nordic recommendation
Nordic recommendation, no restrictions on energy
Behavioral: Dietetic group sessions
Group sessions to improve dietary adherence

Primary Outcome Measures :
  1. Change in six minute walk test from baseline to week 16 (end of study) [ Time Frame: weeks 0 and 16 ]
    Performance measure

Secondary Outcome Measures :
  1. Change in lipid status from baseline to week 16 (end of study). [ Time Frame: weeks 0,1,2,4,6,8,10,12,14,16 ]
    Blood sample and analyses for lipids

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • bmi >30
  • heart failure, moderate to severe, new york heart association II og III
  • stable disease
  • age >18 years
  • out-patients
  • perform a six minutes walk test
  • given consent

Exclusion Criteria:

  • unstable disease
  • insulin treated diabetes
  • pregnancy or lactating
  • unstable weight past 6 months (+- 10 kg)
  • planned procedures in the time of intervention

Layout table for additonal information
Responsible Party: Arne Astrup, Professor, University of Copenhagen Identifier: NCT02105805     History of Changes
Other Study ID Numbers: GEN-01-clinnutr
First Posted: April 7, 2014    Key Record Dates
Last Update Posted: April 7, 2014
Last Verified: April 2014
Keywords provided by Arne Astrup, University of Copenhagen:
intention weight loss
heart failure
6-minute walk test
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Weight Loss
Cardiovascular Diseases
Body Weight Changes
Body Weight
Signs and Symptoms